未登录

S

Shuanglin Liao

guangdong medical university

H指数:6

被引数:109

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tetraspanin-Mediated ADAM10 Regulation in Sepsis and Potential Therapeutic Implications

四跨膜蛋白介导的ADAM10调控在败血症中的作用及潜在的治疗意义

FRONTIERS IN BIOSCIENCE-LANDMARK

IF3.1

2025-09-250

OAAI

Network Pharmacology; Experimental Validation Explored Kakkalide to Ameliorate Endothelial Cell Dysfunction and Inflammatory Response

网络药理学；实验验证探索Kakkalide对改善内皮细胞功能障碍和炎症反应的作用

inflammation research

IF4.1

2025-08-280

OA

RECK as a Potential Crucial Molecule for the Targeted Treatment of Sepsis

inflammation research

IF4.1

2025-02-010

OA

MiR-145 Alleviates Sepsis-Induced Inflammatory Responses and Organ Injury by Targeting ADAM17

FRONTIERS IN BIOSCIENCE-LANDMARK

IF3.1

2024-01-236

OA

The -172 A-to-G variation in ADAM17 gene promoter region affects EGR1/ADAM17 pathway and confers susceptibility to septic mortality with sepsis-3.0 criteria (vol 102, 108385, 2022)

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2023-06-010

OAAI

Genetic Arg-304-His substitution in GRK5 protects against sepsis progression by alleviating NF-?B-mediated inflammation

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2023-02-013

PRE

A comparative evaluation of lasers and photodynamic therapy in the nonsurgical treatment of peri-implant diseases: A Bayesian network meta-analysis

PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY

IF2.6

2022-12-014

OAAI

Efficacy and safety of nafamostat mesilate anticoagulation in blood purification treatment of critically ill patients: a systematic review and meta-analysis

IF3

2022-08-057

OAAI

The-172 A-to-G variation in ADAM17 gene promoter region affects EGR1/ADAM17 pathway and confers susceptibility to septic mortality with sepsis-3.0 criteria

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2022-01-017

OAAI

Investigation of Association of Complement 5 Genetic Polymorphisms with Sepsis and Sepsis-Induced Inflammatory Responses

inflammation research

IF4.1

2021-12-015

OA

A gain-of-function NLRP3 3′-UTR polymorphism causes miR-146a-mediated suppression of NLRP3 expression and confers protection against sepsis progression

SCIENTIFIC REPORTS

IF3.9

2021-06-2511

OAAI